Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer

Cancer Chemotherapy and Pharmacology

Volumn 46, Issue 3, 2000, Pages 221-226

  Knapp, Deborah W ^a   Glickman, Nita W ^a   Widmer, William R ^a   DeNicola, Dennis B ^a   Adams, Larry G ^a   Kuczek, Thomas ^b   Bonney, Patty L ^a   DeGortari, Amalia E ^a   Han, Connie ^a   Glickman, Lawrence T ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Animal models; Bladder cancer; Cisplatin; Cox inhibitors; Piroxicam

Indexed keywords

BUTORPHANOL TARTRATE; CISPLATIN; MISOPROSTOL; PIROXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER REGRESSION; CANCER STAGING; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GASTROINTESTINAL TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; CREATININE; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; DOGS; FEMALE; HUMANS; MALE; PIROXICAM; PROSPECTIVE STUDIES; RANDOM ALLOCATION; URINARY BLADDER NEOPLASMS;

EID: 0033806440     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000147     Document Type: Article

References (27)

1. Biochemical modulation of cisplatin toxicity
2. Regressions and inhibitions of the growth of human lung metastases induced by piroxicam, an inhibitor of prostaglandin synthesis
3. Protection of normal tissues from the cytotoxic effects of chemotherapy by amifostine (ethyol): Clinical experiences
4. Response of canine transitional cell carcinoma of the urinary bladder to cisplatin therapy: A retrospective study of 18 dogs
5. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder
6. The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells
7. Cisplatin nephrotoxicity. A review
8. Clinical implications of selective cyclooxygenase-2 inhibition
9. Medical therapy of canine transitional cell carcinoma of the urinary bladder
10. Naturally occurring cancer in pet dogs: Important models for developing improved cancer therapy for humans
11. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder
12. Evaluation of the in vitro cytotoxicity of nonsteroidal antiinflammatory drugs against canine tumor cells
13. Naturally occurring canine transitional cell carcinoma of the urinary bladder. A relevant model of human invasive bladder cancer
14. Pet populations in the catchment area of the Purdue Comparative Oncology Program
15. Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2
16. Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxicam
17. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
18. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder
19. Cancer of the bladder
20. Renal complications of nonsteroidal anti-inflammatory drugs
21. Aspirin use and reduced risk of fatal colon cancer
22. Cyclooxygenase regulates angiogenesis induced by colon cancer cells